Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMilitary Technology and Strategies · Legal and Regulatory Analysis · Linguistic, Cultural, and Literary Studies
This is a correction to: Adam Ioannou, Paolo Massa, Rishi K Patel, Yousuf Razvi, Aldostefano Porcari, Muhammad U Rauf, Anita Jiang, Giacomo Cabras, Stefano Filisetti, Roos E Bolhuis, Francesco Bandera, Lucia Venneri, Ana Martinez-Naharro, Steven Law, Tushar Kotecha, Ruta Virsinskaite, Daniel S Knight, Michele Emdin, Aviva Petrie, Helen Lachmann, Ashutosh Wechelakar, Mark Petrie, Alun Hughes, Nick Freemantle, Philip N Hawkins, Carol Whelan, John J V McMurray, Julian D Gillmore, Marianna Fontana, Conventional heart failure therapy in cardiac ATTR amyloidosis, European Heart Journal, Volume 44, Issue 31, 14 August 2023, Pages 2893–2907, https://doi.org/10.1093/eurheartj/ehad347
The following change has been made to the original publication of this manuscript. The Data Availability statement has been changed to read: “The data underlying this article cannot be shared due to restrictions from the institutional ethics committee to protect patient privacy.” instead of: “No data were generated or analysed for this manuscript.”